Tema Oncology ETF

Rentabilidad a seis meses: -12.19%
Industria: Health & Biotech Equities

Regeneron
AstraZeneca PLC
Merck & Co
argenx SE
Daiichi Sankyo Company, Limited
Amgen
Chugai Pharmaceutical Co., Ltd.
Blueprint Medicines Corporation
Illumina
Revolution Medicines, Inc.
Descansar
Regeneron: 6.1%AstraZeneca PLC: 5.9%Merck & Co: 4.3%argenx SE: 4.2%Daiichi Sankyo Company, Limited: 3.8%Amgen: 3.8%Chugai Pharmaceutical Co., Ltd.: 3.6%Blueprint Medicines Corporation: 3.3%Illumina: 3.3%Revolution Medicines, Inc.: 3.1%Descansar: 58.7%Compartir compartir por empresaes.porti.ru
Descargar SVG
Descargar PNG
Descargar CSV
NombreIndustriaCompartir, %P/BVP/SP/EEV/EbitdaRendimiento de dividendos
Regeneron Regeneron Healthcare 6.0665 3.71 7.34 24.35 23.78 0.1388
AstraZeneca PLC AstraZeneca PLC Healthcare 5.94354 2.49 1.88 14.45 7.38 1.98
Merck & Co Merck & Co Healthcare 4.26457 7.29 4.56 751.54 40.3 2.82
argenx SE argenx SE Healthcare 4.19048 5.2 17.38 0 -87.37 0
Daiichi Sankyo Company, Limited Daiichi Sankyo Company, Limited Healthcare 3.81885 5.48 5.78 46.09 29.44 1.54
Amgen Amgen Healthcare 3.775 24.53 5.42 22.76 26.16 2.92
Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. Healthcare 3.57457 5.41 7.92 27.04 18.68 2.06
Blueprint Medicines Corporation Blueprint Medicines Corporation Healthcare 3.30318 41.19 21.57 15.98 -12.82 0
Illumina Illumina Healthcare 3.27465 3.85 4.86 39.92 -21.83 0
Revolution Medicines, Inc. Revolution Medicines, Inc. Healthcare 3.12948 1.79 282.39 0 -5.57 0
41.3210.0935.9194.211.811.15

Paga tu suscripción

Más funciones y datos para el análisis de empresas y carteras están disponibles mediante suscripción